Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is a devastating disease with a 5-year survival rate of 12%. Only about 20% of patients are candidates for curative surgery, while the majority receive palliative chemotherapy or best supportive care. Recently, testing chemotherapeutical agents on patient-derived 3-...

Descripción completa

Detalles Bibliográficos
Autores principales: Grützmeier, Simon Ezban, Kovacevic, Bojan, Vilmann, Peter, Rift, Charlotte Vestrup, Melchior, Linea Cecilie, Holmström, Morten Orebo, Brink, Lene, Hassan, Hazem, Karstensen, John Gásdal, Grossjohann, Hanne, Chiranth, Deepthi, Toxværd, Anders, Hansen, Carsten Palnæs, Høgdall, Estrid, Hasselby, Jane Preuss, Klausen, Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377599/
https://www.ncbi.nlm.nih.gov/pubmed/37509338
http://dx.doi.org/10.3390/cancers15143677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377599/
https://www.ncbi.nlm.nih.gov/pubmed/37509338
http://dx.doi.org/10.3390/cancers15143677

Ejemplares similares